Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 4.251% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) COCCN1CCN(C(=O)C2CCC(=O)N(Cc3ccccc3F)C2)CC1
b.) CCOc1cc(N2CCOCC2)c(OCC)cc1NC(=O)c1cc(C)nc2ccccc12
c.) CC(C)Oc1ccc(C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NN)cc1
Answer: c. CC(C)Oc1ccc(C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NN)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)Oc1ccc(C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NN)cc1
CC(C)Oc1ccc(C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NN)cc1
N-[3-(1H-indol-3-yl)-1-hydrazinyl-1-oxopropan-2-yl]-4-propan-2-yloxybenzamide